U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07275775) titled 'Single and Multiple Dose and Food Effect Study to Evaluate the Safety, Tolerability and Pharmacokinetics of D-2570 Tablets in Healthy Subjects' on Nov. 04, 2024.

Brief Summary: This is a randomized, double-blind, placebo-controlled single and multiple ascending dose and food effect study on PK. Subjects in the SAD and MAD study take the drug under fasting conditions, while those in the food effect (FE) study are required to take the drug under fasting or fed conditions according to the protocol.

Study Start Date: Aug. 13, 2024

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: D-2570

D-2570 is a novel inhibitor...